02 Feb MediPurpose Sells 500 Millionth Safety Lancet to IMCO Member MMS Medical
ATLANTA and ST. LOUIS, Mo., Feb. 1 — MediPurpose, a master distributor and manufacturer of medical products, today announced the sale of its 500 millionth SurgiLance safety lancet to MMS Medical of St. Louis, Missouri.
In recognition of the significant milestone, MediPurpose will hold a brief ceremony on Thursday, February 21 at MMS Medical’s office.
“We want all our customers to share in this significant achievement and to know how much they are valued by the MediPurpose team,” says MediPurpose founder and CEO Patrick Yi. “We are committed to continued innovation in healthcare.”
Introduced in 2000, the SurgiLance safety lancet has found long-term success in all sectors of the healthcare market and has provided more than 500 million consumers with a safe, simple and effective tool for blood testing. MediPurpose currently offers six color-coded lancets, which are used for capillary blood sampling for a range of testing requirements.
To help the millions of children living with diabetes, MediPurpose will make a $1,000 donation to the Juvenile Diabetes Research Foundation in the name of MMS Medical.
Walgreens District Manager Chuck Berry, who will accept the donation for JDRF, is also president of the board for the Metro St. Louis/Greater Missouri chapter of JDRF.
MMS Medical is a member of Independent Medical Co-Op (IMCO), a leading cooperative for medical supply distributors.
“We are pleased that one of our members, MMS Medical, is being recognized by MediPurpose, a long-time valued supplier,” said IMCO Vice President Deb Bullock. “We extend our congratulations to MediPurpose and its SurgiLance safety lancet on this significant achievement and look forward to continued growth together.”
“We consider distributors like MMS Medical to be full partners in our success,” said Yi. “Since early 2001, MediPurpose has maintained a strong and vibrant relationship with IMCO and its member companies. They have grown into one of our most valued distribution partners.”
MMS Medical has purchased SurgiLance safety lancets since 2002.
“On behalf of MMS, we would like to congratulate MediPurpose on this sales milestone,” said MMS Vice President Long Term Care Kelly Hart. “We are honored to be a part of the celebration and look forward to our continued partnership to help improve the lives of those with diabetes.”
Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices in the United States and Europe.
Known for its popular babyLance heel incision device, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor that provides unique solutions for both medical product manufacturers and distributors.
MediPurpose’s Medical Device Innovation division offers angel funding and developmental expertise for new medical device inventors and innovative medical product companies that seek entrance into new medical device markets.
For more information about MediPurpose’s medical products and solutions for inventors, innovators, manufacturers and distributors, please visit www.medipurpose.com.